IP Library › Granted Patent US 10,960,230
Granted Patent B2
US 10,960,230 · App. 16/210,590 · Granted Mar 30, 2021

Calibration of hypoxic region focused radiotherapy treatment plans

Inventor: Nam P. Nguyen (Washington, DC)
A61N5/1075A61B6/037A61B6/5217A61N5/1031A61N5/1039A61N5/1064A61N5/1077G01T1/2985A61B6/12A61B6/469A61N2005/1076
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,230
App. No.
16/210,590
Granted
Mar 30, 2021
Kind
B2
Abstract

The present invention features calibration methods for radiotherapy treatment plans. An image-guided radiotherapy system for tumor treatment featuring a hypoxic-region-focused (HRF) radiation dose is calibrated using a phantom. The treatment plans may also feature a boosted dose to the resistance region of the tumor. The HRF radiation dose may be greater than 120% of a predetermined prescribed radiation dose for the tumor.

Claims (20)

1. A method of calibrating a resistance region focused (RRF) dose in a radiotherapy treatment plan for a tumor using a phantom model, the method comprising:

a. obtaining a three-dimensional image of a tumor in a patient;

b. identifying a peripheral boundary of the tumor using the three-dimensional image;

c. identifying a hypoxic region within the tumor using the three-dimensional image;

d. designating a region immediately inside the peripheral boundary as a sensitive region, the sensitive region having an average width W;

e. designating a region between the hypoxic region and the sensitive region as a resistance region;

f. generating a radiation treatment plan, the treatment plan comprising:

i. a hypoxic region focused (HRF) dose, the HRF dose directed to the hypoxic region;

ii. a resistance region focused (RRF) dose, lower than the HRF dose but boosted above a spillover dose from the HRF dose, the RRF dose directed to the resistance region; and

iii. a sensitive region focused (SRF) dose, lower than the RRF dose, the SRF dose directed to the sensitive region;

iv. a tumor boundary dose, lower than a threshold dose;

g. irradiating a phantom following the treatment plan;

h. measuring the irradiation in said phantom;

i. testing the measured irradiation to the phantom region corresponding to the peripheral boundary to determine if the boosted RRF dose had increased irradiation at the peripheral boundary above the threshold value; and

j. calibrating the RRF dose based on the determination of the irradiation to the phantom region corresponding to the peripheral boundary.

2. The method of claim 1 , wherein the tumor is a radiation resistant tumor.

3. The method of claim 1 , wherein the three-dimensional image is obtained using positron-emission tomography (PET).

4. The method of claim 1 , wherein the HRF radiation dose is greater than a prescribed treatment dose for the tumor.

5. The method of claim 1 , wherein the RRF radiation dose is greater than a prescribed treatment dose for the tumor.

6. The method of claim 1 , wherein a combined volume of the resistance region and the hypoxic region is more than 20% of a total volume of the tumor.

Continuity (4)
Continuation In Part 14745188 · Jun 19, 2015
Continuation In Part 14436394
Continuation In Part 13652821 · Oct 16, 2012
Related Publication 20190105516A1 · Apr 11, 2019
Cited By (2)
US 12,582,845 US 12,700,100